Literature DB >> 6381449

Mechanism of action of the new orally active cephalosporin FK027.

Y Shigi, Y Matsumoto, M Kaizu, Y Fujishita, H Kojo.   

Abstract

The mechanism of action of a new orally active cephalosporin, FK027, was compared to that of cephalexin and cefaclor to elucidate its excellent antibacterial activity against Gram-negative bacteria. FK027 showed very high affinity for the penicillin-binding proteins (PBPs) 3, 1a and 1bs of Escherichia coli whereas cephalexin showed fairly high affinity for PBPs 1a, 4 and 3. The ability of FK027 to penetrate the outer membranes of E. coli and Enterobacter cloacae was less than that of cephalexin and cefaclor. However, FK027 was extremely stable to both plasmid-mediated penicillinases and chromosomal beta-lactamases except the Bacteroides fragilis enzyme and its stability was superior to that of cephalexin and cefaclor. These results indicate that the potent antibacterial activity of FK027 is based on its enhanced affinity for the target enzymes and its high stability to beta-lactamases.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6381449     DOI: 10.7164/antibiotics.37.790

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  13 in total

1.  Activity of cefixime against Helicobacter pylori and affinities for the penicillin-binding proteins.

Authors:  F Ikeda; Y Yokota; Y Mine; M Tatsuta
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

2.  Establishment of a Protein Concentration Gradient in the Outer Membrane Requires Two Diffusion-Limiting Mechanisms.

Authors:  Luis David Ginez; Aurora Osorio; Laura Camarena; Sebastian Poggio
Journal:  J Bacteriol       Date:  2019-08-08       Impact factor: 3.490

3.  beta-Lactamase stability and in vitro activity of oral cephalosporins against strains possessing well-characterized mechanisms of resistance.

Authors:  C C Sanders
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

4.  In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.

Authors:  Y Utsui; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

Review 5.  Cephalosporins 1945-1986.

Authors:  E P Abraham
Journal:  Drugs       Date:  1987       Impact factor: 9.546

6.  In vitro activities and targets of three cephem antibiotics against Haemophilus influenzae.

Authors:  P M Mendelman; L L Henritzy; D O Chaffin; K Lent; A L Smith; T L Stull; E A Wiley
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

7.  Novel plasmid-mediated beta-lactamase from Escherichia coli that inactivates oxyimino-cephalosporins.

Authors:  Y Matsumoto; F Ikeda; T Kamimura; Y Yokota; Y Mine
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

8.  Mechanism of therapeutic effectiveness of cefixime against typhoid fever.

Authors:  Y Matsumoto; A Ikemoto; Y Wakai; F Ikeda; S Tawara; K Matsumoto
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

9.  Dose-dependent pharmacokinetics of a new oral cephalosporin, cefixime, in the dog.

Authors:  M Bialer; V K Batra; J A Morrison; B M Silber; Z M Look; A Yacobi
Journal:  Pharm Res       Date:  1987-02       Impact factor: 4.200

10.  Pharmacokinetics of cefixime (CL 284,635; FK 027) in healthy subjects and patients with renal insufficiency.

Authors:  D R Guay; R C Meatherall; G K Harding; G R Brown
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.